Literature DB >> 20037661

Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP).

Oleg A Andreev, Donald M Engelman, Yana K Reshetnyak.   

Abstract

We discuss a peptide that targets cells in the acidic tissues that result from a range of pathological states, including tumours, and that can also translocate cell-impermeable cargo molecules across cell membranes in a pH-dependent manner. The technology is based on the interactions of a water-soluble membrane peptide, which we call pHLIP (pH (Low) Insertion Peptide), with the lipid bilayers of cell membranes. at the normal pH of healthy tissue it binds to cell surfaces, but at low pH pHLIP inserts as a monomer across the cell membrane to form a stable transmembrane helix. pHLIP holds promise for imaging and drug delivery applications.

Entities:  

Year:  2009        PMID: 20037661      PMCID: PMC2796806     

Source DB:  PubMed          Journal:  Chim Oggi        ISSN: 0392-839X


  17 in total

Review 1.  Plasmalemmal vacuolar-type H+-ATPase in cancer biology.

Authors:  Souad R Sennoune; Defeng Luo; Raul Martínez-Zaguilán
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

2.  A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.

Authors:  Yana K Reshetnyak; Michael Segala; Oleg A Andreev; Donald M Engelman
Journal:  Biophys J       Date:  2007-06-08       Impact factor: 4.033

Review 3.  A review of stimuli-responsive nanocarriers for drug and gene delivery.

Authors:  Srinivas Ganta; Harikrishna Devalapally; Aliasgar Shahiwala; Mansoor Amiji
Journal:  J Control Release       Date:  2008-01-11       Impact factor: 9.776

4.  Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells.

Authors:  A H Lee; I F Tannock
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

5.  Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix.

Authors:  J F Hunt; P Rath; K J Rothschild; D M Engelman
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

Review 6.  Genomics-based prognosis and therapeutic prediction in breast cancer.

Authors:  Stefanie S Jeffrey; Per Eystein Lønning; Bruce E Hillner
Journal:  J Natl Compr Canc Netw       Date:  2005-05       Impact factor: 11.908

7.  Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane.

Authors:  Yana K Reshetnyak; Oleg A Andreev; Michael Segala; Vladislav S Markin; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

8.  Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors.

Authors:  Manuela Zoonens; Yana K Reshetnyak; Donald M Engelman
Journal:  Biophys J       Date:  2008-03-21       Impact factor: 4.033

9.  Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.

Authors:  Oleg A Andreev; Allison D Dupuy; Michael Segala; Srikanth Sandugu; David A Serra; Clinton O Chichester; Donald M Engelman; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

10.  Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.

Authors:  Naomi Robertson; Christian Potter; Adrian L Harris
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

View more
  27 in total

1.  pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path.

Authors:  Oleg A Andreev; Alexander G Karabadzhak; Dhammika Weerakkody; Gregory O Andreev; Donald M Engelman; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 2.  The use of therapeutic peptides to target and to kill cancer cells.

Authors:  R J Boohaker; M W Lee; P Vishnubhotla; J M Perez; A R Khaled
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

3.  Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.

Authors:  Yana K Reshetnyak; Lan Yao; Sida Zheng; Sergey Kuznetsov; Donald M Engelman; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

4.  Comparison of lipid-dependent bilayer insertion of pHLIP and its P20G variant.

Authors:  Victor Vasquez-Montes; Janessa Gerhart; Kelly E King; Damien Thévenin; Alexey S Ladokhin
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-11-11       Impact factor: 3.747

5.  Folding of diphtheria toxin T-domain in the presence of amphipols and fluorinated surfactants: Toward thermodynamic measurements of membrane protein folding.

Authors:  Alexander Kyrychenko; Mykola V Rodnin; Mauricio Vargas-Uribe; Shivaji K Sharma; Grégory Durand; Bernard Pucci; Jean-Luc Popot; Alexey S Ladokhin
Journal:  Biochim Biophys Acta       Date:  2011-09-17

6.  pH-Dependent Cellular Internalization of Paramagnetic Nanoparticle.

Authors:  Branislava Janic; Mohammed Pi Bhuiyan; James R Ewing; Meser M Ali
Journal:  ACS Sens       Date:  2016-08-10       Impact factor: 7.711

7.  Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.

Authors:  Kelly E Burns; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2015-03-13       Impact factor: 4.939

Review 8.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 9.  Applications of pHLIP Technology for Cancer Imaging and Therapy.

Authors:  Linden C Wyatt; Jason S Lewis; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Trends Biotechnol       Date:  2017-04-21       Impact factor: 19.536

10.  Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP).

Authors:  James Segala; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Int J Mol Sci       Date:  2009-08-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.